Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-03-15 @ 2:26 AM
Study NCT ID:
NCT01307618
Status:
TERMINATED
Last Update Posted:
2016-10-24
First Post:
2011-03-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization: